Dianthus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%), etc.
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(5.1%),TCG Crossover Fund II, L.P.(5.1%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(5.9%),VHCP Co-Investment Holdings III, LLC(5.9%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-5AM Ventures VII, L.P.(3.5%),5AM Partners VII, LLC(3.5%), etc.
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Octagon Capital Advisors LP(6.0%),Ting Jia(6.0%), etc.
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Romano Steven J.
Dianthus Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Romano Steven J.
Dianthus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viridian, LLC(3.72%)
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CARR EDWARD
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Veness Adam M
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Randhawa Simrat
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Savitz Ryan
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Garcia Marino
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Violin Jonathan
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Soteropoulos Paula
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOULDER LEON O JR
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McGeorge Anne